Leonidas Koliastasis (@lkoliastasis) 's Twitter Profile
Leonidas Koliastasis

@lkoliastasis

MD, MSc, PhD, Cath Lab GNA Ippokration Athens, CHU St-Pierre, Brussels

ID: 1108367631688577025

calendar_today20-03-2019 14:00:10

178 Tweet

493 Followers

474 Following

Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

Trial after trial, and with safer stent platforms, dual antiplatelet therapy (DAPT) durations are decreasing. But are we ready to eliminate DAPT entirely? We wrote this viewpoint to summarize the evolutionary journey of trials on aspirin-free strategies after percutaneous

Trial after trial, and with safer stent platforms, dual antiplatelet therapy (DAPT) durations are decreasing. But are we ready to eliminate DAPT entirely? We wrote this viewpoint to summarize the evolutionary journey of trials on aspirin-free strategies after percutaneous
Leonidas Koliastasis (@lkoliastasis) 's Twitter Profile Photo

Another trial adding data to a hot topic. It seems like despite FFR is absolutely indicated to guide our interventions in stable CAD, things are getting blurry in ACS. FULL REVASC also provided insights (different design). #cardiobot #cardiotwitter #circ #circIntv #PCRonline

Leonidas Koliastasis (@lkoliastasis) 's Twitter Profile Photo

My review on PCRonline 🫀 Prehospital loading with crushed prasugrel in STEMI with a large myocardial area at risk improves TIMI flow PCRonline 🫀 pcronline.com/tiny/url/775972

PCRonline 🫀 (@pcronline) 's Twitter Profile Photo

Read this #EAPCI/PCR Journal Club review ✍️ of a pre-specified substudy of the CompareCrush trial 📊which aimed to examine if #STEMI patients with a large myocardial infarction benefit from prehospital crushed prasugrel. 🔗 pcronline.com/PCR-Publicatio… Reviewed by Leonidas Koliastasis

Read this #EAPCI/PCR Journal Club review ✍️ of a pre-specified substudy of the CompareCrush trial 📊which aimed to examine if #STEMI patients  with a large myocardial infarction benefit from prehospital crushed  prasugrel.

🔗 pcronline.com/PCR-Publicatio…

Reviewed by <a href="/LKoliastasis/">Leonidas Koliastasis</a>
Leonidas Koliastasis (@lkoliastasis) 's Twitter Profile Photo

Valvular disease treatment evolution requires new tools. The new #EasyCross catheter may aid prosthetic valve crossing. First-in-human experience with EasyCross: a novel catheter for a safe and correct aortic valve crossing via PCRonline 🫀 pcronline.com/tiny/url/777878

HCSYoung (@hcs_young) 's Twitter Profile Photo

"Fellowship opportunities 'n' certifications for the Young Cardiologist" A practical #webinar with great to-the-point speakers and panelists! #Young Cardiologists are shaping the future of cardiology clinical practice! Christina Chrysohoou Leonidas Koliastasis Chris Kapelios Aristi Boulmpou

"Fellowship opportunities 'n' certifications for the Young Cardiologist" 
A practical #webinar with great to-the-point speakers and panelists! #Young Cardiologists are shaping the future of cardiology clinical practice! <a href="/chrysohoou/">Christina Chrysohoou</a> <a href="/LKoliastasis/">Leonidas Koliastasis</a> <a href="/CKapelios/">Chris Kapelios</a>     
<a href="/aristi_boulmpou/">Aristi Boulmpou</a>
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

In the new issue, we address one of the most debated topics of the moment, drug-coated balloons, with 5 articles and some editorials in a minifocus that tell you how the field is evolving and may deserve some of your time. Specifically: - A viewpoint on the treatment of acute

In the new issue, we address one of the most debated topics of the moment, drug-coated balloons, with 5 articles and some editorials in a minifocus that tell you how the field is evolving and may deserve some of your time. Specifically:
-  A viewpoint on the treatment of acute
Leonidas Koliastasis (@lkoliastasis) 's Twitter Profile Photo

Sailing in the Aegean Sea has now gained recommendation I A for CVD Prevention! 🌊⚓️⛵️ #CVD #Prevention #EAPC #PCRonline #Aegean

Sailing in the Aegean Sea has now gained recommendation I A for CVD Prevention! 🌊⚓️⛵️ #CVD #Prevention #EAPC #PCRonline #Aegean
EuroIntervention (@eurointerventio) 's Twitter Profile Photo

📍Drug-coated balloons (DCBs) for acute coronary syndromes 📍 This rapidly expanding area shows promising results, offering a simplified, stent-free approach for high-risk PCI patients, including those with STEMI and OOHCA. Main Points: 🔹 Non-inferiority of DCBs vs. DES in

📍Drug-coated balloons (DCBs) for acute coronary syndromes 📍
This rapidly expanding area shows promising results, offering a simplified, stent-free approach for high-risk PCI patients, including those with STEMI and OOHCA. 

Main Points: 
🔹 Non-inferiority of DCBs vs. DES in
Leonidas Koliastasis (@lkoliastasis) 's Twitter Profile Photo

When only one arterial access (left radial) available and you have to engage RIMA then you have to be creative. JL4 with a BMW wire made it. No support nor wire length to exchange so I trapped the wire with a BP cuff in the right brachial #PCRonline #CardioTwitter #Radialfirst

When only one arterial access (left radial) available and you have to engage RIMA then you have to be creative. JL4 with a BMW wire made it. No support nor wire length to exchange so I trapped the wire with a BP cuff in the right brachial #PCRonline #CardioTwitter #Radialfirst
Leonidas Koliastasis (@lkoliastasis) 's Twitter Profile Photo

Ultrasound ❓ Guided puncture ✅ No sign. difference in that trial but when comes to a no-cost, no-risk, no-fluoro, no-contrast technique with added security I always vote yes! #PCRonline eurointervention.pcronline.com/article/ultras…

Ultrasound ❓ 
Guided puncture ✅
No sign. difference in that trial but when comes to a no-cost, no-risk, no-fluoro, no-contrast technique with added security I always vote yes! #PCRonline 
eurointervention.pcronline.com/article/ultras…
EAPCIPresident (@eapcipresident) 's Twitter Profile Photo

301 #EAPCI members have applied for committee membership Members from every #EAPCI country have applied with Italy 🇮🇹Germany 🇩🇪and Poland 🇵🇱leading the way The results of this first-ever open call for all #EAPCI members will be announced soon Stay tuned